| 5 |
Kruger B, Banas MC, Walberer A, et al. A comprehensive genotype-phenotype interaction of different Toll-like receptor variations in a renal transplant cohort[J]. Clin Sci, 2010, 119(12): 535-544.
|
| 6 |
Dhillon N, Walsh L, Kruger B, et al. A single nucleotide polymorphism of Toll-like receptor 4 identifies the risk of developing graft failure after liver transplantation[J]. J Hepatol, 2010, 53(1): 67-72.
|
| 7 |
Ducloux D, Deschamps M, Yannaraki M, et al. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation[J]. Kidney Int, 2005, 67(6): 2454-2461.
|
| 8 |
Eid AJ, Brown RA, Paya CV, et al. Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus[J]. Transplantation, 2007, 84(4): 511-516.
|
| 9 |
Hwang YH, Ro H, Choi I, et al. Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation[J]. Transplantation, 2009, 88(5): 699-705.
|
| 10 |
Kastelijn EA, van Moorsel CH, Rijkers GT, et al. Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation[J]. J Heart Lung Transplant, 2010, 29(6): 665-671.
|
| 11 |
Naesens M, Butte AJ, Sarwal MM. C3 polymorphisms and outcomes of renal allografts[J]. N Engl J Med, 2009, 360(23): 2478-2479.
|
| 12 |
Naesens M, Li L, Ying L, et al. Expression of complement components differs between kidney allografts from living and deceased donors[J]. J Am Soc Nephrol, 2009, 20(8):1839-1851.
|
| 13 |
Li L, Wadia P, Chen R, et al. Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures[J]. Proc Natl Acad Sci USA, 2009, 106(11): 4148-4153.
|
| 14 |
Sutherland SM, Li L, Sigdel TK, et al. Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients[J]. Kidney Int, 2009, 76(12): 1277-1283.
|
| 15 |
Li L, Chen A, Chaudhuri A, et al. Compartmental localization and clinical relevance of MICA antibodies after renal transplantation[J]. Transplantation, 2010, 89(3): 312-319.
|
| 16 |
Zou Y, Stastny P, Susal C, et al. Antibodies against MICA antigens and kidney-transplant rejection[J]. N Engl J Med, 2007, 357(13):1293-1300.
|
| 17 |
Vasconcellos LM, Schachter AD, Zheng XX, et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts[J]. Transplantation，1998, 66(5): 562-566.
|
| 18 |
Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling[J]. N Engl J Med, 2003, 349(2): 125-138.
|
| 19 |
Hertz MI, Aurora P, Christie JD, et al. Scientific Registry of the International Society for Heart and Lung Transplantation: introduction to the 2009 Annual Reports[J]. J Heart Lung Transplant, 2009, 28(10): 989-992.
|
| 20 |
Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States[J]. Am J Kidney Dis, 2012, 59(1 Suppl 1):A7, e1-e420.
|
| 21 |
Choy JC. Granzymes and perforin in solid organ transplant rejection[J]. Cell Death Differ, 2010, 17(4): 567-576.
|
| 22 |
Kotsch K, Mashreghi MF, Bold G, et al. Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection[J]. Transplantation, 2004, 77(12): 1866-1875.
|
| 23 |
Galante NZ, Camara NO, Kallas EG, et al. Noninvasive immune monitoring assessed by flow cytometry and real time RT-PCR in urine of renal transplantation recipients[J]. Transpl Immunol, 2006, 16(2): 73-80.
|
| 24 |
Krukemeyer MG, Moeller J, Morawietz L, et al. Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection[J]. Transplantation, 2004, 78(1): 65-70.
|
| 25 |
Hauser IA, Spiegler S, Kiss E, et al. Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG)[J]. J Am Soc Nephrol, 2005, 16(6): 1849-1858.
|
| 26 |
Schaub S, Nickerson P, Rush D, et al. Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis[J]. Am J Transplant, 2009, 9(6): 1347-1353.
|
| 27 |
Belperio JA, Keane MP, Burdick MD, et al. Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection[J]. J Immunol, 2003, 171(9): 4844-4852.
|
| 28 |
Hancock WW, Gao W, Csizmadia V, et al. Donor-derived IP-10 initiates development of acute allograft rejection[J]. J Exp Med, 2001, 193(8): 975-980.
|
| 29 |
Shyu AB, Wilkinson MF, van Hoof A. Messenger RNA regulation: to translate or to degrade[J]. EMBO J, 2008, 27(3): 471-481.
|
| 30 |
Anglicheau D, Sharma VK, Ding R, et al. MicroRNA expression profiles predictive of human renal allograft status[J]. Proc Natl Acad Sci USA, 2009, 106(13): 5330-5335.
|
| 31 |
O′Connell RM, Kahn D, Gibson WS, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development[J]. Immunity, 2010, 33(4): 607-619.
|
| 32 |
Harris A, Krams SM, Martinez OM. MicroRNAs as immune regulators: implications for transplantation[J]. Am J Transplant, 2010, 10(4): 713-719.
|
| 33 |
Dall A, Hariharan S. BK virus nephritis after renal transplantation[J]. Clin J Am Soc Nephrol, 2008, 3(Suppl 2): S68-S75.
|
| 34 |
Zarkhin V, Kambham N, Li L, et al. Characterization of intra-graft B cells during renal allograft rejection[J]. Kidney Int, 2008, 74(5): 664-673.
|
| 35 |
Dragun D, Müller DN, Bräsen JH, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection[J]. N Engl J Med, 2005, 352(6): 558-569.
|
| 36 |
Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival[J]. Am J Transplant, 2007, 7(2): 408-415.
|
| 1 |
Gautam A, Morrissey PE, Brem AS, et al. Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder[J]. Pediatr Transplant, 2006, 10(5): 613-616.
|
| 2 |
Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay[J]. Transplantation, 2006, 82(5): 663-668.
|
| 3 |
Terasaki P, Lachmann N, Cai J. Summary of the effect of de novo HLA antibodies on chronic kidney graft failure[J]. Clin Transpl, 2006:455-462.
|
| 4 |
Israni A, Leduc R, Holmes J, et al. Single-nucleotide polymorphisms, acute rejection, and severity of tubulitis in kidney transplantation, accounting for center-to-center variation[J]. Transplantation, 2010, 90(12): 1401-1408.
|
| 37 |
Lerut E, Van Damme B, Noizat-Pirenne F, et al. Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection？[J]. Transfusion, 2007, 47(1): 28-40.
|
| 38 |
Joosten SA, Sijpkens YW, van Ham V, et al. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy[J]. Am J Transplant, 2005, 5(2): 383-393.
|
| 39 |
Chen R, Sigdel TK, Li L, et al. Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions[J]. PLoS Comput Biol, 2010, 6(9): e1000940.
|
| 40 |
Veale JL, Liang LW, Zhang Q, et al. Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts[J]. Hum Immunol, 2006, 67(10): 777-786.
|
| 41 |
Alakulppi NS, Kyllonen LE, Partanen J, et al. Diagnosis of acute renal allograft rejection by analyzing whole blood mRNA expression of lymphocyte marker molecules[J]. Transplantation, 2007, 83(6): 791-798.
|
| 42 |
Graziotto R, Del Prete D, Rigotti P, et al. Perforin, Granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues[J]. Transplantation, 2006, 81(8): 1125-1132.
|
| 43 |
Sarwal MM, Jani A, Chang S, et al. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation[J]. Hum Immunol, 2001, 62(1): 21-31.
|
| 44 |
Li B, Hartono C, Ding R, et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine[J]. N Engl J Med, 2001, 344(13): 947-954.
|
| 45 |
Sis B, Jhangri GS, Bunnag S, et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining[J]. Am J Transplant, 2009, 9(10): 2312-2323.
|
| 46 |
Ihn H. Pathogenesis of fibrosis: role of TGF-beta and CTGF[J]. Curr Opin Rheumatol, 2002, 14(6): 681-685.
|
| 47 |
Booth AJ, Csencsits-Smith K, Wood SC, et al. Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection[J]. Am J Transplant, 2010, 10(2): 220-230.
|
| 48 |
Shi Y, Tu Z, Bao J, et al. Urinary connective tissue growth factor increases far earlier than histopathological damage and functional deterioration in early chronic renal allograft injury[J]. Scand J Urol Nephrol, 2009, 43(5): 390-399.
|
| 49 |
Luo GH, Lu YP, Song J, et al. Inhibition of connective tissue growth factor by small interfering RNA prevents renal fibrosis in rats undergoing chronic allograft nephropathy[J]. Transplant Proc, 2008, 40(7): 2365-2369.
|
| 50 |
Ho J, Rush DN, Gibson IW, et al. Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts[J]. Transplantation, 2010, 90(4): 394-400.
|
| 51 |
van Timmeren MM, van den Heuvel MC, Bailly V, et al. Tubular kidney injury molecule-1 (KIM-1) in human renal disease[J]. J Pathol, 2007, 212(2): 209-217.
|
| 52 |
Han WK, Bailly V, Abichandani R, et al. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury[J]. Kidney Int, 2002, 62(1): 237-244.
|
| 53 |
Malyszko J, Koc-Zorawska E, Malyszko JS, et al. Kidney injury molecule-1 correlates with kidney function in renal allograft recipients[J]. Transplant Proc, 2010, 42(10): 3957-3959.
|
| 54 |
van Timmeren MM, Vaidya VS, van Ree RM, et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients[J]. Transplantation, 2007, 84(12): 1625-1630.
|
| 55 |
Zhou Y, Vaidya VS, Brown RP, et al. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium[J]. Toxicol Sci, 2008, 101(1): 159-170.
|
| 56 |
Kurian SM, Heilman R, Mondala TS, et al. Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood[J]. PLoS One, 2009, 4(7): e6212.
|
| 57 |
Ashton-Chess J, Giral M, Mengel M, et al. Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection[J]. J Am Soc Nephrol, 2008, 19(6): 1116-1127.
|
| 58 |
Orlando G, Hematti P, Stratta RJ, et al. Clinical operational tolerance after renal transplantation: current status and future challenges[J]. Ann Surg, 2010, 252(6): 915-928.
|
| 59 |
Martínez-Llordella M, Lozano JJ, Puig-Pey I, et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients[J]. J Clin Invest, 2008, 118(8): 2845-2857.
|
| 60 |
Newell KA, Asare A, Kirk AD, et al. Identification of a B cell signature associated with renal transplant tolerance in humans[J]. J Clin Invest, 2010, 120(6): 1836-1847.
|
| 61 |
Sagoo P, Perucha E, Sawitzki B, et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans[J]. J Clin Invest, 2010, 120(6): 1848-1861.
|